Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-14

Clinical Trial Update: Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluates calcium dobesilate versus coasting for prevention of ovarian hyperstimulation syndrome in infertility patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium dobesilate (calcium dobesilate)

Snippet

Sponsor: khalid abd aziz mohamed | Conditions: Infertility | Phase 2, Phase 3 | Status: COMPLETED